Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of ASN100 for prevention of Staphylococcus aureus pneumonia in mechanically ventilated colonized subjects
MOH_2017-04-25_000331Phase 2Not yet recruiting
- Sponsor
- Arsanis
- Start
- Mar 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in staphylococcal pneumonia comparing ASN100 with Placebo (2 arms). Planned start Mar 2017; status: not yet recruiting.
02
Drugs
ASN100
03
Conditions
staphylococcal pneumonia
Beyond the preview
Go deeper on MOH_2017-04-25_000331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-04-25_000331.